CoonerW.H., MosleyB.R., RutherfordC.L.Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990; 1146–1154.
4.
BabaianR.J., DinneyC.P., RamirezE.I.Diagnostic testing for prostate cancer detection: less is best. Urology.1993; 41: 421–425.
5.
RuckleH.C., KleeG.G., OesterlingJ.E.Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc.1994; 69: 59–68.
6.
CatalonaW.J., SmithD.S., RatliffT.L.Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med.1991; 324: 1156–1161.
7.
BrawerM.K., ChetnerM.P., BeatieJ.Screening for prostatic carcinoma with prostate specific antigen. J Urol.1992; 147: 841–845.
8.
OesterlingJ.E., JacobsenS.J., ChuteC.G.Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA.1993; 270: 860–864.
9.
MiddletonR.G., ThompsonI.M., AustenfeldM.S.Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. J Urol.1995; 154: 2144–2148.
10.
BlaskoJ.C., WallnerK., GrimmP.D.Prostate specific antigen based disease control following ultrasound guided [125]iodine implantation for stage T1/T2 prostatic carcinoma. J Urol.1995; 154: 1096–1099.
11.
ChodakG.W., ThistedR.A., GerberG.S.Results of conservative management of clinically localized prostate cancer. N Engl J Med.1994; 330: 242–248.
